BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16847929)

  • 1. Rituximab in a child with relapsed Burkitt lymphoma.
    Bay A; Dogan M; Acikgoz M; Oner AF
    Pediatr Blood Cancer; 2007 Aug; 49(2):218. PubMed ID: 16847929
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustained complete remission following a combination of very low intensity chemotherapy with rituximab in an elderly patient with Burkitt's lymphoma.
    Cohen Y; Amir G; Rachmilewitz EA; Polliack A
    Haematologica; 2002 Jan; 87(1):ELT04. PubMed ID: 11801488
    [No Abstract]   [Full Text] [Related]  

  • 3. Refractoriness to rituximab monotherapy in a child with relapsed/refractory Burkitt non-Hodgkin lymphoma.
    Okur FV; Oguz A; Karadeniz C; Citak C; Poyraz A; Boyunaga O
    Pediatr Hematol Oncol; 2006; 23(1):25-31. PubMed ID: 16326409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favorable outcome with chemo-immunotherapy in Burkitt lymphoma and leukemia.
    Griskevicius L; Stulpinas R; Vengalyte I; Saulyte-Trakymiene S; Mickys U; Pranys D; Kurtinaitis J; Jurgutis M
    Leuk Res; 2009 Apr; 33(4):587-8. PubMed ID: 18762337
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of relapsed meningeal Burkitt's leukemia/lymphoma treated with intraventricular rituximab combined with high-dose cytarabine.
    Billio A; Svaldi M; Morello E; Amato B; Coser P
    Am J Hematol; 2006 Oct; 81(10):798-9. PubMed ID: 16838326
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment with modified CHOP-rituximab in pediatric AIDS-related advanced stage Burkitt lymphoma.
    Crosswell HE; Bergsagel DJ; Yost R; Lew G
    Pediatr Blood Cancer; 2008 Apr; 50(4):883-5. PubMed ID: 17278123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab in three children with relapsed/refractory B-cell acute lymphoblastic leukaemia/Burkitt non-Hodgkin's lymphoma.
    de Vries MJ; Veerman AJ; Zwaan CM
    Br J Haematol; 2004 May; 125(3):414-5. PubMed ID: 15086431
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients.
    Oriol A; Ribera JM; Bergua J; Giménez Mesa E; Grande C; Esteve J; Brunet S; Moreno MJ; Escoda L; Hernandez-Rivas JM; Hoelzer D
    Cancer; 2008 Jul; 113(1):117-25. PubMed ID: 18457327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Maxillofacial location of Burkitt lymphoma at the University Hospital Center of Ouagadougou, Burkina Faso].
    Ouoba K; Dao M; Sakande B; Kabre M; Cisse R; Sanou A
    Med Trop (Mars); 1997; 57(4):415-6. PubMed ID: 9612790
    [No Abstract]   [Full Text] [Related]  

  • 10. [Burkitt's lymphoma in HIV-infected patients].
    Kath R; Günzel K; Höffken K; Schmidt CG; Donhuijsen K
    Dtsch Med Wochenschr; 1990 Aug; 115(34):1293-4. PubMed ID: 2390943
    [No Abstract]   [Full Text] [Related]  

  • 11. [Non-Hodgkin lymphomas of the Burkitt type].
    Herrero Díez A; Lamamie de Clairac P; Muro Brussi M; Meana Meana A; Donoro Mazario M
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():112-3. PubMed ID: 3214015
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study.
    Sebban C; Brice P; Delarue R; Haioun C; Souleau B; Mounier N; Brousse N; Feugier P; Tilly H; Solal-Céligny P; Coiffier B
    J Clin Oncol; 2008 Jul; 26(21):3614-20. PubMed ID: 18559872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic results in Burkitt's lymphoma].
    López J; Melero C; Montalbán MA; García-Muñoz F; Nazario G; Valverde F; Gil C; Bernacer M; Aracil J; Contra T
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():141-4. PubMed ID: 3214024
    [No Abstract]   [Full Text] [Related]  

  • 14. Bezafibrate and medroxyprogesterone acetate in resistant and relapsed endemic Burkitt lymphoma in Malawi; an open-label, single-arm, phase 2 study (ISRCTN34303497).
    Molyneux E; Merrick B; Khanim FL; Banda K; Dunn JA; Iqbal G; Bunce CM; Drayson MT
    Br J Haematol; 2014 Mar; 164(6):888-90. PubMed ID: 24266453
    [No Abstract]   [Full Text] [Related]  

  • 15. Rituximab as monotherapy and in addition to reduced CHOP in children with primary immunodeficiency and non-Hodgkin lymphoma.
    Shabbat S; Aharoni J; Sarid L; Ben-Harush M; Kapelushnik J
    Pediatr Blood Cancer; 2009 May; 52(5):664-6. PubMed ID: 19142990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of ICE-rituximab chemotherapy and subsequent bone marrow transplantation in a patient with early-relapse Burkitt leukemia and inverted duplication of 1q.
    Malbora B; Avci Z; Olgac A; Gursel O; Kurekci E; Ozbek N
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):e84-5. PubMed ID: 22258345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab-combination chemotherapy achieves a 10th cycle of remission for Burkitt's lymphoma.
    Umeda K; Fujino H; Saida S; Kato I; Hiramatsu H; Yamada T; Hori T; Adachi S; Heike T; Watanabe K
    Pediatr Int; 2015 Apr; 57(2):e30-3. PubMed ID: 25868956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burkitt's lymphoma-- what is new?
    Abinya ON
    East Afr Med J; 2008 May; 85(5):205-6. PubMed ID: 18814529
    [No Abstract]   [Full Text] [Related]  

  • 19. Early response observed in pediatric patients with relapsed/refractory Burkitt lymphoma treated with chimeric antigen receptor T cells.
    Zhang W; Yang J; Zhou C; Hu B; Jin L; Deng B; Liu Y; Wang S; Chang AH; Du J; Gao Z; Zhang Y
    Blood; 2020 Jun; 135(26):2425-2427. PubMed ID: 32321169
    [No Abstract]   [Full Text] [Related]  

  • 20. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
    Al-Ali HK; Wittekind C; Niederwieser D
    Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.